Chinook Therapeutics logo
Chinook Therapeutics KDNY
report update icon

Quarterly report 2023-Q2
added 11-21-2026

Chinook Therapeutics Total Shareholders Equity | KDNY

Annual Total Shareholders Equity Chinook Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
442 M 454 M 335 M -41.1 M -681 K 237 M 227 M 262 M -61.3 M -38.8 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
454 M -61.3 M 181 M

Quarterly Total Shareholders Equity Chinook Therapeutics

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
357 M 412 M 442 M 475 M 507 M 427 M 454 M 270 M 297 M 301 M 335 M -72.2 M -53.8 M -46.4 M -41.1 M 82 M 101 M 115 M -681 K 158 M 176 M 197 M 237 M 256 M 258 M 229 M 227 M 250 M 246 M 240 M 262 M 243 M 241 M -77.3 M -61.3 M -61.3 M -61.3 M -61.3 M -38.8 M - - - -27.7 M - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
507 M -77.3 M 180 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer Total Shareholders Equity Price % 24h Market Cap Country
Annexon Annexon
ANNX
212 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
63.9 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-27.2 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
3.24 B - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
7.16 M - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.83 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
15.8 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
21.5 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
154 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
27.3 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
98.7 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
4.16 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
57.4 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
928 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-473 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
2.53 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
11.8 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
750 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
205 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
78.4 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
8.15 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
46.8 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
234 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
156 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
15.1 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
163 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-4.08 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
-914 K - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-8.44 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
-45.3 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
6.12 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
188 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
176 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-31.5 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
31.8 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
44.6 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
-11.9 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
39.1 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
76.4 M - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
149 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
10.7 M - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
69.5 M - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
992 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-16.8 M - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
22.7 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
207 M $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
597 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
954 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
-37.5 M - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
141 M - - $ 58.1 M usaUSA